Patient-Reported Outcomes Data Can Be Used In Labeling, FDA Draft Guidance Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Document outlines the evaluation and development of appropriate PRO instruments to collect outcomes data that supports labeling claims.